Generation of Four IPSC Lines from Peripheral Blood Mononuclear Cells (PBMCs) of an Attention Deficit Hyperactivity Disorder (ADHD) Individual and a Healthy Sibling in an Australia-Caucasian Family
Overview
Authors
Affiliations
Peripheral blood mononuclear cells were donated by a male teenager with clinically diagnosed attention deficit hyperactivity disorder (ADHD) under the Diagnostic and Statistical Manual of Mental Disorders IV criteria and his unaffected male sibling. Induced pluripotent stem cells were developed using integration-free Sendai Reprogramming factors containing OCT4, SOX2, KLF4, and c-MYC. All four iPSC lines displayed pluripotent cell morphology, pluripotency-associated factors at the DNA and protein level, alkaline phosphatase enzymatic activity and a male karyotype of 46, XY. All lines had capacity for in vitro differentiation into all the three germ layers. All were negative for Mycoplasma.
Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies.
Pazzin D, Previato T, Goncalves J, Zanirati G, Xavier F, Da Costa J Cells. 2024; 13(9.
PMID: 38727281 PMC: 11083827. DOI: 10.3390/cells13090745.
Namipashaki A, Pugsley K, Liu X, Abrehart K, Lim S, Sun G Stem Cell Reports. 2023; 18(12):2515-2527.
PMID: 37977144 PMC: 10724053. DOI: 10.1016/j.stemcr.2023.10.013.
Promising Developments in the Use of Induced Pluripotent Stem Cells in Research of ADHD.
Yde Ohki C, McNeill R, Nieberler M, Radtke F, Kittel-Schneider S, Grunblatt E Curr Top Behav Neurosci. 2022; 57:483-501.
PMID: 35543866 DOI: 10.1007/7854_2022_346.
Genetics in the ADHD Clinic: How Can Genetic Testing Support the Current Clinical Practice?.
Balogh L, Pulay A, Rethelyi J Front Psychol. 2022; 13:751041.
PMID: 35350735 PMC: 8957927. DOI: 10.3389/fpsyg.2022.751041.
Unterholzner J, Millischer V, Wotawa C, Sawa A, Lanzenberger R Int J Neuropsychopharmacol. 2021; 24(10):759-775.
PMID: 34216465 PMC: 8538891. DOI: 10.1093/ijnp/pyab037.